5-7 February 2020 Hague
![]() |
![]() |
![]() |
![]() |
P-001 | ONE STAGE AND CHROMOGENIC FVIII ASSAY RESULTS AT TROUGH LEVELS: A UK NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEME FOR BLOOD COAGULATION (UK NEQAS BC) EXERCISE. | Anna Lowe | ![]() |
![]() |
|||
P-002 | HUMAN CHROMOGENIC FVIII ASSAY RESULTS ARE DEPENDENT ON SAMPLE DILUTION WHEN EMICIZUMAB IS PRESENT: ADDITIONAL ANALYSIS FROM THE FIRST UK NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEME FOR BLOOD COAGULATION (UK NEQAS BC) FVIII INHIBITOR/EMICIZIMAB SUPPLEMENTARY EXERCISE. | Anna Lowe | ![]() |
![]() |
|||
P-003 | LABORATORY MEASUREMENT OF EMICIZUMAB FIRST REAL-LIFE EXPERIENCE FROM KAROLINSKA UNIVERSITY LABORATORY | Anna Sjstrm | ![]() |
![]() |
|||
P-006 | DELAYS IN THE DIAGNOSIS OF ACQUIRED HAEMOPHILIA IN THREE MEN DUE TO PROLONGED APTTS AND SEVERE BRUISING BEING INITIALLY ATTRIBUTED TO ORAL ANTICOAGULANT THERAPY | Charlene Neill | ![]() |
![]() |
|||
P-007 | METHODOLOGICAL VALIDATION OF THE MEASUREMENT OF ULTRA-LOW LEVELS OF FACTOR VIII ACTIVITY BY CHRONOMETRIC APTTBASED ASSAY. | Clémentine WAHL | ![]() |
![]() |
|||
P-018 | GENETIC DIAGNOSIS AND MOLECULAR EPIDEMIOLOGY DESCRIPTION OF A COHORT OF 109 HEMOPHILIC CUBANS. | Nina Borràs | ![]() |
![]() |
|||
P-021 | CHARACTERIZATION OF A NEW CHROMOGENIC FACTOR VIII ASSAY CONTAINING HUMAN FIXA AND BOVINE FX. | Pia Bryngelhed | ![]() |
![]() |
|||
P-024 | EMICIZUMAB ASSOCIATES WITH ACTIVATED FXI AND INTRINSIC PATHWAY OF COAGULATION CAPTURED BY THROMBOELASTOGRAPHY AND CORN TRYPSIN INHIBITOR | Timea Szanto | ![]() |
![]() |
|||
P-044 | ASSESSING A POPULATION PHARMACOKINETIC MODEL OF A PLASMA-DERIVED, VON WILLEBRAND FACTOR-CONTAINING FVIII CONCENTRATE FOR BAYESIAN FORECASTING IN LOW DOSE SCENARIOS | Dr. Edginton | ![]() |
![]() |
|||
P-045 | SUCCESSFUL LASER REFRACTIVE EYE SURGERY DURING TREATMENT WITH CONCIZUMAB IN A PATIENT WITH SEVERE HAEMOPHILIA A WITH AN INHIBITOR | Alison Delaney | ![]() |
![]() |
|||
P-057 | RESULTS OF A PHASE 1 REPEAT DOSE OF BIVV001 A NEW CLASS OF FACTOR VIII REPLACEMENT THERAPY | Liza ORourke | ![]() |
![]() |
|||
P-059 | ASSESSING THE MINIMUM AND IDEAL FACTOR LEVELS FOR PARTICIPATION IN PHYSICAL ACTIVITIES BY PEOPLE WITH HAEMOPHILIA: AN EXPERT ELICITATION STUDY | Antony Martin | ![]() |
![]() |
|||
P-061 | REAL LIFE, LONG-TIME DOCUMENTATION ON THE USE OF A SINGLE PLASMATIC FACTOR IX CONCENTRATE | Artur Bauhofer | ![]() |
![]() |
|||
P-076 | COMPARATIVE EFFECTIVENESS AND SAFETY, AND HEALTH-RELATED QUALITY OF LIFE OF HAEMOPHILIA A TREATMENTS: A SYSTEMATIC REVIEW | Charles Hawes | ![]() |
![]() |
|||
P-077 | COMPARING THE SENSITIVITY OF PATIENT-LEVEL DISCRETE EVENT SIMULATION AND COHORT HEALTH-STATE TRANSITION MODELLING FRAMEWORKS IN THE ADVENT OF NOVEL THERAPIES FOR PEOPLE WITH SEVERE HAEMOPHILIA A. | charles hawes | ![]() |
![]() |
|||
P-080 | TREATMENT PATTERNS OF FVIII PRODUCTS FOR HAEMOPHILIA A IN SWEDEN ANALYSIS OF NATIONAL REAL WORLD DATA | Christian Gerdeskold | ![]() |
![]() |
|||
P-087 | SUCCESSFUL EXPERIENCE EMICIZUIMAB: ZERO T.A.S | Mauricio Jaramillo | ![]() |
![]() |
|||
P-097 | DEVELOPMENT AND TESTING OF THE ONLINE PROBE SURVEY AND THE MYPROBE APP AND INTEGRATION WITH THE CANADIAN BLEEDING DISORDER REGISTRY | Federico Germini | ![]() |
![]() |
|||
P-103 | TIME TO NEGATIVE INHIBITOR TITRE IN SEVERE HAEMOPHILIA A PATIENTS WITH LOW TITRE INHIBITORS IS SIMILAR REGARDLESS OF ITI TREATMENT; DATA FROM PEDNET COHORT | Marloes de Kovel | ![]() |
![]() |
|||
P-119 | CLINICAL MANAGEMENT OF WOMEN WITH BLEEDING DISORDERS: RESULTS OF A SURVEY AMONG EUROPEAN HEMOPHILIA TREATMENT CENTERS | Karin van Galen | ![]() |
![]() |
|||
P-125 | QUALITY OF LIFE IN HAEMOPHILIC PATIENTS FROM A NORTHERN REGION OF SPAIN. | Angel Bernardo Gutiérrez | ![]() |
![]() |
|||
P-126 | EVALUATION OF PAIN AND FUNCTIONAL CAPACITY IN HAEMOPHILIC PATIENTS IN A NORTHERN REGION OF SPAIN. | LAURA ESCALADA GONZALEZ | ![]() |
![]() |
|||
P-139 | BRAVE BLEEDING RATES IN HEMOPHILIA A: REAL-WORLD EVIDENCES IN BRAZIL | Albertina Rosa Borges | ![]() |
![]() |
|||
P-145 | HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MILD HAEMOPHILIA: A PROSPECTIVE OBSERVATIONAL STUDY | Mariasanta Napolitano | ![]() |
![]() |
|||
P-147 | THE WORLD BLEEDING DISORDERS REGISTRY CELEBRATES 2 YEARS | Mayss Naccache | ![]() |
![]() |
|||
P-152 | JOINT STATUS AND HEALTH RELATED QUALITY OF LIFE IN ADULTS WITH HEMOPHILIA IN MOROCCO. | Najia Belhaj | ![]() |
![]() |
|||
P-155 | IMPACT OF THE AVAILABILITY OF EXTENDED HALF-LIFE FACTOR VIII ON THE TREATMENT MODALITIES OF PATIENTS WITH SEVERE HAEMOPHILIA A IN THE NORTHWEST AREA OF FRANCE (MOTHIF II STUDY) | Nicolas DRILLAUD | ![]() |
![]() |
|||
P-175 | POWER: AN INNOVATIVE APPROACH FOR CLINICAL STUDY DESIGN BASED ON STRUCTURED CO-CREATION BETWEEN INDUSTRY, PHYSICIANS, ACADEMIA AND PATIENTS ASSOCIATIONS. | Rosaria Tempre | ![]() |
![]() |
|||
P-177 | INTERNATIONAL STANDARD SET OF HEALTH OUTCOMES THAT MATTER FOR PEOPLE LIVING WITH HEMOPHILIA | Samantha Gouw | ![]() |
![]() |
|||
P-179 | COLLABORATION OF CARE TO ENABLE ACCESS TO NEW MEDICINES FOR PATIENTS NOT REGISTERED WITH A COMPREHENSIVE CARE CENTRE | Sarah Johns | ![]() |
![]() |
|||
P-216 | QUALITY OF LIFE IN HEMOPHILIA AND VON WILLEBRAND DISEASE PATIENTS IN BOSNIA AND HERZEGOVINA | Emina Suljovic-Hadzimesic | ![]() |
![]() |
|||
P-244 | CORRECTING FVII DEFICIENCY USING COAGULATION FACTORS PRODUCED IN VIVO BY ENCAPSULATED ENGINEERED ALLOGENEIC CELLS | Jelena Garafalo | ![]() |
![]() |
|||
P-273 | DOLPHIN: DEVELOPMENT OF A HAEMOPHILIA PHYSIOTHERAPY INTERVENTION FOR OPTIMUM MUSCULOSKELETAL HEALTH INTERIM RESULTS OF A RANDOMISED CONTROLLED TRIAL | David Stephensen | ![]() |
![]() |
|||
P-274 | IDENTIFYING PERFORMANCE-BASED OUTCOME MEASURES OF PHYSICAL FUNCTION IN PEOPLE WITH HAEMOPHILIA (IPOP) | David Stephensen | ![]() |
![]() |
|||
P-283 | HEMFITBIT - AN OBSERVATIONAL STUDY OF PHYSICAL ACTIVITY IN TEENAGERS AND YOUNG ADULTS WITH HAEMOPHILIA A | Ruth Elise Matlary | ![]() |
![]() |
|||
P-295 | HEMOVE - THE HEMOPHILIA LIFESTYLE COACH - AN EXTRAORDINARY PILOT PROJECT | Ann Devos | ![]() |
![]() |
|||
P-298 | HAEMOPHILIA CARRIERS EXPERIENCE STUDY: LIFE CHOICES, PSYCHOSOCIAL NEEDS AND PARENTING (CARES) | Sarah Mangles | ![]() |
![]() |
|||
P-300 | SOCIAL SUPPORT AND RESILIENCE IN PATIENTS SUFFERING WITH SEVERE HAEMOPHILIA AND INHIBITORS FIRST ANALYSIS OF THE PILOT PROJECT | Kate&345;ina Ratajová | ![]() |
![]() |
5-7 February 2020 Hague
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|